A Study of Amivantamab in People With Esophagogastric Cancer
Clinical trial NCT05117931 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05117931
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-02
- Primary completion
- 2026-11-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.